EXOSYSTEMS Inc.

EXOSYSTEMS PRODUCTS

exoPill
AI-powered wearable home helathcare solution

Product Outline
- 'exoPill' is a digital healthcare device for musculoskeletal functionality
improvement and pain relief.
- Its multiple attachable modules can be attached to the skin of the muscle
area on any part of the body to provide treatment such as electrical
stimulation to improve musculoskeletal functions or relieving pain, and
bio-signal measurement such as muscle condition.
- US HS Code: 9018. 90. 6000 ‘Electro-surgical instruments and appliances,
other than extracorporeal shock wave lithotripters; all the foregoing and
parts and accessories thereof’

Major Product Features
- exoPill is a next-generation product focusing on rehabilitation of neurotic
patients by inheriting major technologies of our previous product.
1) All-in-one healthcare technology
2) Composite analysis and management of bio-signals through AI
3) AI-powered analysis and customized recommendation

exoRehab
Telehealth mobile Platform

Product Outline
‘exoRehab’ is a remote therapeutic monitoring (RTM) solution developed by EXOSYSTEMS to enhance the continuity and effectiveness of home-based rehabilitation.
combines wearable sensors, a patient-facing mobile app, and a clinician dashboard to enable real-time monitoring of exercise performance.

Major Product Features
Through electromyography (EMG) and motion data, exoRehab not only verifies whether prescribed exercises are performed, but also evaluates how accurately and consistently they are executed.
Allows clinicians to detect compensatory movements, adjust prescriptions, and provide personalized feedback remotely.
Supports bidirectional communication, helping maintain engagement and treatment quality outside the clinic.

exoFit
AI-powered exercise performance assessment
and monitoring platform

Product Outline
‘exoFit’ is All-in-One exercise management solution from pre-exercise consultation to real-time feedback during workouts and post-exercise analysis
Unlike traditional body composition analyzers or 3D scanners that focus on external physique, exoFit analyzes intrinsic muscle function and dynamic performance.
Designed for use across athletic training, rehabilitation, and fitness, exoFit provides objective data on muscle activation, movement patterns, and compensatory behaviors

Major Product Features
By applying EMG/IMU technology, utilized by pro teams and medical experts, ‘exoFit’ evaluate and monitor the functional status of muscles, including muscle activity, fatigue, and left-right balance
Enable muscle activation & movement tracking with Wearable device
Provides Casual/Professional assessment report for 7 test items / 14 detailed metrics (Strength/Endurance/Fatigue/Balance/Flexibility/Gait pattern/Core Stability) 

EXOSYSTEMS Inc. was established as a spin-off company of ETRI (Electron-ics and Telecommunications Research Institute) in 2017 and the goal is to commercialize the AI-powered healthcare with our technology.

Our main focus fields are digital medical devices and digital therapeutics.
The digital medical device focus on saving time and money for those in need of post-neurotic surgery rehabilitation. Also, we focus our capabilities on developing technology and products that can be used comfortably and consistently for rehabilitation at home and can improve the health status of the elderly, whose physical functions naturally weaken due to aging.

Based on our unique robotics and ICT technology capabilities, we are developing musculoskeletal healthcare products that can be used for the aged population which takes up the majority of the modern society. 

Healthcare and Beyond
EXOSYSTEMS EXOSYSTEMS
CERTIFICATES

Main Products

Company Profile

Welcome !
Welcome to our e-catalog home.
Here you can find information about our products. You can also send us inquiries and post comments about our company and products.
We hope you enjoy your visit.

EXOSYSTEMS Inc., a 2017 spin-off from ETRI, develops AI-powered digital biomarkers that quantify neuromuscular function using evoked EMG signals.

Its core technology enables the detection of muscular abnormalities and functional decline. With 70% of its team holding advanced degrees,
the company holds 15 patents and has led over KRW 10 billion in national healthcare R&D.

EXOSYSTEMS was also selected for Korea’s ARPA-H-equivalent program and the U.S.-based PharmStars accelerator.
  • Response Level
      51% ~ 70%
  • Supplier Level
      1 million to 10 billion(KRW)
  • Transaction Level
      less than 5